1.
PET Imaging of Tau Deposition in the Aging Human Brain
by Schöll, Michael
Neuron (Cambridge, Mass.), 2016, Vol.89 (5), p.971-982
2.
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
by Sperling, Reisa
Neuron (Cambridge, Mass.), 2014, Vol.84 (3), p.608-622
3.
Plasma phospholipids identify antecedent memory impairment in older adults
by Mapstone, Mark
Nature medicine, 2014, Vol.20 (4), p.415-418
4.
Nutritional and cognitive relationships and long-term mortality in patients with various dementia disorders
by Faxén-Irving, Gerd
Age and ageing, 2005, Vol.34 (2), p.136-141
5.
Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease
by Lam, Alice D
Nature medicine, 2017, Vol.23 (6), p.678-680
6.
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
by Zhang, Zhentao
Nature medicine, 2014, Vol.20 (11), p.1254-1262
7.
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease
by Litvinchuk, Alexandra
Neuron (Cambridge, Mass.), 2018, Vol.100 (6), p.1337-1353.e5
8.
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
by Jo, Seonmi
Nature medicine, 2014, Vol.20 (8), p.886-896
9.
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
by Nelson, Peter T
Journal of neuropathology and experimental neurology, 2012, Vol.71 (5), p.362-381
10.
Inflammation in Alzheimer disease: driving force, bystander or beneficial response?
by Wyss-Coray, Tony
Nature medicine, 2006, Vol.12 (9), p.1005-1015
11.
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
by Banerjee, Sube, Prof
The Lancet (British edition), 2011, Vol.378 (9789), p.403-411
12.
Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease
by Cifuentes, Diana
Hypertension (Dallas, Tex. 1979), 2015, Vol.65 (1), p.218-224
13.
Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer's disease
by Šišková, Zuzana
Neuron (Cambridge, Mass.), 2014, Vol.84 (5), p.1023-1033
14.
Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis
by Wang, Jun
Journal of neurology, neurosurgery and psychiatry, 2015, Vol.86 (1), p.101-109
15.
Vulnerability to Stress, Anxiety, and Development of Dementia in Old Age
by Wilson, Robert S., Ph.D
The American journal of geriatric psychiatry, 2011, Vol.19 (4), p.327-334
16.
Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease
by Palop, Jorge J
Neuron (Cambridge, Mass.), 2007, Vol.55 (5), p.697-711
17.
Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults
by Devanand, D.P., M.D
The American journal of geriatric psychiatry, 2016, Vol.24 (12), p.1151-1157
18.
Longitudinal Relationships Between Alzheimer Disease Progression and Psychosis, Depressed Mood, and Agitation/Aggression
by Zahodne, Laura B., Ph.D
The American journal of geriatric psychiatry, 2015, Vol.23 (2), p.130-140
19.
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion
by Khan, Baber K
Journal of neurology, neurosurgery and psychiatry, 2012, Vol.83 (4), p.358-364
20.
Diagnostic Precision in the Detection of Mild Cognitive Impairment: A Comparison of Two Approaches
by Weinstein, Andrea M
The American journal of geriatric psychiatry, 2022, Vol.30 (1), p.54-64
